Literature DB >> 18097457

Treatment of metastatic urachal carcinoma in an elderly woman.

Supriya G Mohile1, Lori Schleicher, Daniel P Petrylak.   

Abstract

BACKGROUND: A 67-year-old woman with a history of smoking presented with abdominal pain and hematuria. On physical examination, she had a palpable pelvic mass. Imaging revealed a large pelvic mass situated on the dome of the bladder, extending from the urachus, without evidence of other sites of metastases. After resection, urachal adenocarcinoma was histologically confirmed. No adjuvant therapy was administered. Repeat imaging obtained 3 months after resection revealed a large left pelvic mass consistent with recurrence. INVESTIGATIONS: Physical examination, pelvic and complete lymph-node examination, laboratory tests, urine analysis, CT scan of the abdomen and pelvis, chest X-ray, bone scan, cystoscopy, histologic examination of tumor morphology, and MRI of the abdomen and pelvis. DIAGNOSIS: Metastatic urachal adenocarcinoma. MANAGEMENT: Surgical excision combined with cystectomy and pelvic lympadenectomy, chemotherapy with 5-fluorouracil, leucovorin, and irinotecan.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18097457     DOI: 10.1038/ncponc1009

Source DB:  PubMed          Journal:  Nat Clin Pract Oncol        ISSN: 1743-4254


  11 in total

Review 1.  Variant forms of bladder cancer: basic considerations on treatment approaches.

Authors:  Francesc Pons; Anna Orsola; Juan Morote; Joaquim Bellmunt
Journal:  Curr Oncol Rep       Date:  2011-06       Impact factor: 5.075

2.  A case of metastatic urachal adenocarcinoma treated with several different chemotherapeutic regimens.

Authors:  Christine Elser; Joan Sweet; Sendhil K Cheran; Masoom A Haider; Michael Jewett; Srikala S Sridhar
Journal:  Can Urol Assoc J       Date:  2012-02       Impact factor: 1.862

Review 3.  Chemotherapy for bladder cancer in patients with impaired renal function.

Authors:  Steve Nicholson
Journal:  Nat Rev Urol       Date:  2011-11-22       Impact factor: 14.432

4.  Cisplatin and S-1 for urachal carcinoma: A single-institution case series.

Authors:  Tetsuya Urasaki; Yoichi Naito; Nobuaki Matsubara; Masaoki Sasaki; Takahiro Kogawa; Ako Hosono
Journal:  IJU Case Rep       Date:  2019-04-09

5.  Angiomatous leiomyoma of the urachus: A rare entity masquerading as extraluminal gastrointestinal stromal tumor.

Authors:  Mani Anand; Sanjay D Deshmukh; Harveen K Gulati; Savita S Ladkat; Sandeep E Jadhav; Snehal N Purandare
Journal:  Urol Ann       Date:  2013-07

6.  Prognostic factors for urachal cancer: a bayesian model-averaging approach.

Authors:  In Kyong Kim; Joo Yong Lee; Jong Kyou Kwon; Jae Joon Park; Kang Su Cho; Won Sik Ham; Sung Joon Hong; Seung Choul Yang; Young Deuk Choi
Journal:  Korean J Urol       Date:  2014-09-05

7.  Rare presentation of urachal adenocarcinoma with skip metastasis to colon.

Authors:  Rakesh Kapoor; Niharika Darasani; Anshuma Bansal
Journal:  Indian J Urol       Date:  2016 Jul-Sep

Review 8.  Urachal adenocarcinoma that metastasized to breast was misinterpreted as primary breast mucinous carcinoma: A rare case report and literature review.

Authors:  Xiang-Rong Zhao; Chao Gao; Yong Zhang; Lei Kong; Wei Qu; Jia Li; Yong-Sheng Gao; Yong-Hua Yu
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

9.  Metastatic Urachal Carcinoma Treated With Several Different Combined Regimens: A Case Report.

Authors:  Han Zheng; Wei Song; Xiemin Feng; Hong Zhao
Journal:  Front Oncol       Date:  2021-07-16       Impact factor: 6.244

Review 10.  Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.

Authors:  Henning Reis; Ulrich Krafft; Christian Niedworok; Orsolya Módos; Thomas Herold; Mark Behrendt; Hikmat Al-Ahmadie; Boris Hadaschik; Peter Nyirady; Tibor Szarvas
Journal:  Dis Markers       Date:  2018-03-12       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.